Insulin signaling, glucose metabolism, and the angiotensin II signaling system: Studies in Bartter's/Gitelman's syndromes [12]

Diabetes Care

Volumn 29, Issue 2, 2006, Pages 469-471

  Davis, Paul A ^a   Pagnin, Elisa ^b   Semplicini, Andrea ^b   Avogaro, Angelo ^b   Calò, Lorenzo A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II; GLUCOSE; GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN; INSULIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE DEPENDENT KINASE 1; PHOSPHOTRANSFERASE; PROTEIN KINASE B; PROTEIN P66; REACTIVE OXYGEN METABOLITE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; PROTEIN SERINE THREONINE KINASE; RHO KINASE; RHO-ASSOCIATED KINASE; SIGNAL PEPTIDE;

GENETIC DISORDER; GLUCOSE METABOLISM; HUMAN; HYPOKALEMIA; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; LETTER; ORAL GLUCOSE TOLERANCE TEST; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM DEPLETION; BARTTER SYNDROME; CASE CONTROL STUDY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; BARTTER SYNDROME; CASE-CONTROL STUDIES; GLUCOSE; HUMANS; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 33646360605     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/diacare.29.02.06.dc05-2048     Document Type: Letter

References (23)

1. Taniyama Y, Hitomi H, Shah A, Alexander RW, Griendling KK: Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II. Arterioscler Thromb Vasc Biol 25:1142-1147, 2005
2. Calò LA, Pessina AC, Semplicini A: Angiotensin II signaling in the Bartter's and Gitelman's syndromes, a negative human model of hypertension. High Blood Press Cardiovasc Prev 12:17-26, 2005
3. Naesens M, Steels P, Verberckmoes R, Vanrenterghem Y, Kuypers D: Bartter's and Gitelman's syndromes: from gene to clinic (Review). Nephron Physiol 96:65-78, 2004
4. Calò LA: A mirror instead of a looking glass to understand vascular tone control in humans: the utility of studies in Bartter's/Gitelmen's syndromes. Kidney Int. In press
5. Calò LA, Pagnin E, Davis PA, Sartori M, Ceolotto G, Pessina AC, Semplicini A: Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's sydrome: a role in the control of vascular tone and implication for hypertension. J Clin Endocrinol Metab 89:4153-4157, 2004
6. Calò L, Ceolotto G, Milani M, Pagnin E, van den Heuvel LP, Sartori M, Davis PA, Costa R, Semplicini A: Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes. Kidney Int 60:882-889, 2001
7. Calò L, Davis PA, Semplicini A: Reduced content of alpha subunit of Gq protein in monocytes of Bartter and Gitelman syndromes: relationship with vascular hyporeactivity. Kidney Int 61:353-354, 2002
8. Di Virgilio F, Calò L, Cantaro S, Favaro S, Piccoli A, Borsatti A: Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome. Clin Sci 72:483-488, 1987
9. Calò L, D'Angelo A, Cantaro S, Rizzolo M, Favaro S, Antonello A, Borsatti A: Intracellular calcium signalling and vascular reactivity in Bartter's syndrome. Nephron 72:570-573, 1996
10. Calò L, Davis PA, Milani M, Cantaro S, Antonello A, Favaro S, D'Angelo A: Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome: relationship to vascular reactivity. Clin Nephrol 51:12-17, 1999
11. - and cyclic GMP levels in patients with Bartter's syndrome: relationship to vascular reactivity. Am J Kidney Dis 27:874-879, 1996
12. Calò L, Cantaro S, Calabro A, Piarulli F, Rizzolo M, Favaro S, Antonello A, Crepaldi G, Borsatti A: Endothelium-derived vasoactive substances in Bartter's syndrome. Angiology 46:905-913, 1995
13. Calò LA, Pagnin E, Davis PA, Sartori M, Semplicini A: Oxidative stress related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling. Nephrol Dial Transplant 18: 1518-1525, 2003
14. Calò L, Sartore G, Bassi A, Basso C, Bertocco S, Marin R, Zambon S, Cantaro S, D'Angelo A, Davis PA, Manzato E, Crepaldi G: Reduced susceptibility of low density lipoprotein to oxidation in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome). J Hypertens 16:1001-1008, 1998
15. Wolfrum S, Dendorfer A, Rikitake Y, Stalker TJ, Gong Y, Scalia R, Dominiak P, Liao PK: Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3 kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol 24:1842-1847, 2004
16. Sowers JR: Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol 286:H1597-H1602, 2004
17. Pagnin E, Davis PA, Sartori M, Semplicini A, Pessina AC, Calò LA: Rho kinase and PAI-1 in Bartter's/Gitelman's syndromes: relationship to angiotensin II signaling. J Hypertens 22:1963-1969, 2004
18. Pagnin E, Semplicini A, Sartori M, Pessina AC, and Calò LA: Reduced mRNA and protein content of Rho guanine nucleotide exchange factor (RhoGEF) in Bartter's and Gitelman's syndromes: relevance for the pathophysiology of hypertension. Am J Hypertens 18:1200-1205, 2005
19. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ: A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24: 539-548, 2001
20. Mita S, Kobayashi N, Yoshida K, Nakano S, Matsuoka H: Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats. J Hypertens 23:87-96, 2005
21. Martin D, Rojo AI, Salinas M, Diaz R, Gallardo G, Alam J, De Galarreta CM, Cuadrado A: Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem 279:8919-8929, 2004
22. Avogaro A, Pagnin E, Calo L: Monocyte NADPH oxidase subunit p22(phox) and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: relationship with oxidative stress. J Clin Endocrinol Metab 88:1753-1759, 2003
23. Pagnin E, Fadini G, de Toni R, Tiengo A, Calo L, Avogaro A: Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress. J Clin Endocrinol Metab 90:1130-1136, 2005